Cargando…
Case report: reuse of tirofiban leads to very severe thrombocytopenia
BACKGROUND: Telofiban is a class of small molecule non-peptide tyrosine derivatives containing RGD sequences. It is the only platelet surface glycoprotein (GP) IIb/IIIa receptor antagonist (GPI) currently marketed in China. In patients with ST-segment elevation myocardial infarction(STEMI) who recei...
Autores principales: | Li, Yuqing, Qiu, Jiuchun, Gao, Yi, Li, Guangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235486/ https://www.ncbi.nlm.nih.gov/pubmed/37273872 http://dx.doi.org/10.3389/fcvm.2023.1130552 |
Ejemplares similares
-
Severe thrombocytopenia following tirofiban infusion
por: Panduranga, Prashanth, et al.
Publicado: (2011) -
Tirofiban-induced thrombocytopenia
por: Wang, Jun, et al.
Publicado: (2023) -
Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report
por: Wang, Ze-Mu, et al.
Publicado: (2023) -
Preclinical multi-target strategies for myocardial ischemia-reperfusion injury
por: Li, Yuqing, et al.
Publicado: (2022) -
Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect
por: Rawala, Muhammad Shabbir, et al.
Publicado: (2020)